Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report

Recently published observational data suggests an increased risk of herpes zoster infection post-vaccination with the BNT162b2 mRNA vaccine. We describe the case of VZV meningitis post BNT162b2 mRNA vaccination in a young immunocompetent patient. A 39-year-old patient with no medical history present...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Colm, O’Neill, Susan, Szucs, Anna, Darmody, Oliver, Williamson, Claire, Bannan, Ciaran, Merry, Concepta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837498/
https://www.ncbi.nlm.nih.gov/pubmed/35186672
http://dx.doi.org/10.1016/j.idcr.2022.e01452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837498/
https://www.ncbi.nlm.nih.gov/pubmed/35186672
http://dx.doi.org/10.1016/j.idcr.2022.e01452

Ejemplares similares